Literature DB >> 23883819

Estradiol downregulates NF-κb translocation by Ikbkg transcriptional repression in dendritic cells.

S Lasarte1, D Elsner, T Sanchez-Elsner, A Fernandez-Pineda, L A López-Fernández, A L Corbí, M A Muñoz-Fernandez, M Relloso.   

Abstract

To reconcile immunity and reproduction, females must allow spermatozoa to survive and control the presence of commensal microbiota and sexually transmitted pathogens during ovulation. Female steroid sex hormones exert a powerful effect on the immune system, as do the hormonal changes associated with the ovarian cycle. Dendritic cells (DCs) are immunological sentinels that link innate immunity to adaptive immunity. Upon exposure to microbial invaders in tissue, they undergo a maturational process that culminates in the lymph nodes and activates T-cell-specific immune responses. Estradiol, which is highly expressed during ovulation, has an effect on the maturation of DCs, although the molecular mechanism remains elusive. We detected that estradiol regulates expression of Ikbkg in DCs and modulates nuclear factor-κb translocation to the nucleus, thus explaining the reduced DC function observed during ovulation. This change may be an adaptive mechanism to reconcile control of infection and reproductive functions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23883819     DOI: 10.1038/gene.2013.35

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  4 in total

Review 1.  Sex Drives Dimorphic Immune Responses to Viral Infections.

Authors:  Soumitra Ghosh; Robyn S Klein
Journal:  J Immunol       Date:  2017-03-01       Impact factor: 5.422

Review 2.  Estrogen receptors regulate innate immune cells and signaling pathways.

Authors:  Susan Kovats
Journal:  Cell Immunol       Date:  2015-02-07       Impact factor: 4.868

Review 3.  Neuroimmunomodulation by estrogen in health and disease.

Authors:  Hannah P Priyanka; Rahul S Nair
Journal:  AIMS Neurosci       Date:  2020-10-30

4.  Sex Difference of Egfr Expression and Molecular Pathway in the Liver: Impact on Drug Design and Cancer Treatments?

Authors:  Lishi Wang; Jianqi Xiao; Weikuan Gu; Hong Chen
Journal:  J Cancer       Date:  2016-03-20       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.